Ceftazidime Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Ceftazidime Market: By Disease Condition (Meningitis, Pneumonia, Sepsis, Urinary Tract Infections, Joint Infections, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Ceftazidime Market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 due to their wide spread usage in the treatment of intra-abdominal, skin and soft tissue, as well as obstetric and gynecological infections and increasing prevalence of various infections are the major factors that are driving the growth of the ceftazidime market. Moreover, implementation of government initiatives, technological advancements and rise in research and developmental activities and product innovations fuels the growth of the market. Additionally, robust development of the healthcare sector and pharmaceutical industry and expanding patient base across the globe to boost the growth of the Ceftazidime market. Also, rising concerns among the patient is propelling the manufacturers to conduct researches with regards to the antibiotics. Global ceftazidime market is surging owing to launch of innovative products in different markets to expand the portfolio and strengthen their position in the market. For instance, in March 2017, Pfizer Inc. announced that Zavicefta, a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gram-negative bacterial infections requiring hospitalization, is now available in the U.K. and Germany. For instance, Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for marketing the injections containing 1 Gm/Vial Ceftazidime, which is used for treating various kinds of infections.

 

Ceftazidime Market

MARKET SUMMARY
-
X%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– X%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Ceftazidime Market

  • Ceftazidime Market gives historical, current, and future market sizes (US$ Mn) of product type and distribution channel and geographic regions.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of Infant nutrition
Market Key Players
  • Covis Pharma
  • DAWNRAYS
  • Hisun
  • CNCM
  • QILU
  • YONGNING
  • WOCK HARDT
  • HOSPIRA
  • ACS Dobfar
  • CSPC
  • HGPF
Growth

Ceftazidime Market

Prevalence of bacterial infections has been raised dramatically in the past years. According to WHO, Sepsis is estimated to affect more than 30 million people worldwide every year, potentially leading to 6 million deaths. The burden of sepsis is most likely highest in low- and middle- income countries. Moreover, increasing population across the world coupled with rise in infectious diseases are expected to fuel the growth of the market over the forecasted years.


North-America Got Significant Share

Ceftazidime Market

North America accounted for larger revenue share in global ceftazidime market with significant CAGR and is expected to grow with highest CAGR during the forecast period owing to rising adoptions of modern technology, burgeoning demands, and advancements in the healthcare infrastructure, rising requisites for dealing with varied infections, increasing treatment procedures across the region, and rise in the healthcare expenditure. Europe and Asia Pacific are expected to show robust growth in the market due to advancements in the healthcare sector and extended patient base in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

KEY FEATURES OF THE REPORT

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Ceftazidime Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Executive Summary
  2. Global Ceftazidime Market Introduction
    • Global Ceftazidime Market – Taxonomy
    • Global Ceftazidime Market –Definitions
      • By Disease Condition
      • By Distribution Channel
      • By Region
  1. Global Ceftazidime Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Ceftazidime Market Dynamics – Factors Impact Analysis
  2. Global Ceftazidime Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Ceftazidime Market Forecast, By Disease Condition, 2014 – 2018 and Forecast, 2019 – 2025
    • Meningitis
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pneumonia
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Gynecological Infections
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Sepsis
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Urinary Tract Infections
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pseudomonas Aeruginosa Infection
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Joint Infections
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Ceftazidime Market Forecast, By Distribution Channel, 2014 – 2018 and Forecast, 2019 – 2025
    • Hospital Pharmacy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Ceftazidime Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Ceftazidime Market – Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Region, 2019 – 2025
  2. North America Ceftazidime Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Disease Condition Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Ceftazidime Market – Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 – 2025
    • North America Ceftazidime Market Dynamics – Trends
  3. Europe Ceftazidime Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Disease Condition Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Europe Ceftazidime Market – Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 – 2025
    • Europe Ceftazidime Market Dynamics – Trends
  4. Asia Pacific Ceftazidime Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Disease Condition Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • China
      • Japan
      • India
      • ASEAN Counties
      • Philippines
      • Rest of Asia Pacific
    • Asia Pacific Ceftazidime Market – Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 – 2025
    • Asia Pacific Ceftazidime Market Dynamics – Trends
  5. Latin America Ceftazidime Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Disease Condition Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Mexico
      • Brazil
      • Argentina
      • Chile
      • Rest of Latin America
    • Latin America Ceftazidime Market – Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 – 2025
    • Latin America Ceftazidime Market Dynamics – Trends
  6. Middle East and Africa Ceftazidime Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Disease Condition Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • GCC Countries
      • South Africa
      • Saudi Arabia
      • Turkey
      • Rest of MEA
    • Middle East and Africa Ceftazidime Market – Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 – 2025
    • Middle East and Africa Ceftazidime Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • Covis Pharma
      • DAWNRAYS
      • Hisun
      • CNCM
      • QILU
      • YONGNING
      • WOCK HARDT
      • HOSPIRA
      • ACS Dobfar
      • CSPC
      • HGPF
  8. Research Methodology
  9. Key Assumptions and Acronyms

Report

Company Profile

  • Covis Pharma
  • DAWNRAYS
  • Hisun
  • CNCM
  • QILU
  • YONGNING
  • WOCK HARDT
  • HOSPIRA
  • ACS Dobfar
  • CSPC
  • HGPF

Description

Ceftazidime Market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 due to their wide spread usage in the treatment of intra-abdominal, skin and soft tissue, as well as obstetric and gynecological infections and increasing prevalence of various infections are the major factors that are driving the growth of the ceftazidime market. Moreover, implementation of government initiatives, technological advancements and rise in research and developmental activities and product innovations fuels the growth of the market. Additionally, robust development of the healthcare sector and pharmaceutical industry and expanding patient base across the globe to boost the growth of the Ceftazidime market. Also, rising concerns among the patient is propelling the manufacturers to conduct researches with regards to the antibiotics. Global ceftazidime market is surging owing to launch of innovative products in different markets to expand the portfolio and strengthen their position in the market. For instance, in March 2017, Pfizer Inc. announced that Zavicefta, a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gram-negative bacterial infections requiring hospitalization, is now available in the U.K. and Germany. For instance, Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for marketing the injections containing 1 Gm/Vial Ceftazidime, which is used for treating various kinds of infections.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX